Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.

DelBello MP, Hochadel TJ, Portland KB, Azzaro AJ, Katic A, Khan A, Emslie G.

J Child Adolesc Psychopharmacol. 2014 Aug;24(6):311-7. doi: 10.1089/cap.2013.0138. Epub 2014 Jun 23.

2.

Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI.

Burch D, Asgharnejad M, Gerson W, Fielding RM, Azzaro AJ.

Clin Pharmacol Drug Dev. 2014 Jan;3(1):4-12. doi: 10.1002/cpdd.61. Epub 2013 Oct 22.

PMID:
27128224
3.

Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.

Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, Burch D, Brand B, Free J, Asgharnejad M, Wang GJ, Telang F, Hubbard B, Jayne M, King P, Carter P, Carter S, Xu Y, Shea C, Muench L, Alexoff D, Shumay E, Schueller M, Warner D, Apelskog-Torres K.

Neuropsychopharmacology. 2010 Feb;35(3):623-31. doi: 10.1038/npp.2009.167. Epub 2009 Nov 4.

4.
5.

Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.

Robinson DS, Gilmor ML, Yang Y, Moonsammy G, Azzaro AJ, Oren DA, Campbell BJ.

Psychopharmacol Bull. 2007;40(3):15-28.

PMID:
18007565
6.
7.
8.

Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.

Azzaro AJ, Ziemniak J, Kemper E, Campbell BJ, VanDenBerg C.

J Clin Pharmacol. 2007 Feb;47(2):146-58.

PMID:
17244765
9.

Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.

Blob LF, Sharoky M, Campbell BJ, Kemper EM, Gilmor MG, VanDenberg CM, Azzaro AJ.

CNS Spectr. 2007 Jan;12(1):25-34.

PMID:
17192761
10.

Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.

Azzaro AJ, Vandenberg CM, Blob LF, Kemper EM, Sharoky M, Oren DA, Campbell BJ.

J Clin Pharmacol. 2006 Aug;46(8):933-44. Erratum in: J Clin Pharmacol. 2006 Oct;46(10):1225-6. Dosage error in article text.

PMID:
16855078
11.

Tyramine pharmacokinetics and reduced bioavailability with food.

VanDenBerg CM, Blob LF, Kemper EM, Azzaro AJ.

J Clin Pharmacol. 2003 Jun;43(6):604-9.

PMID:
12817523
13.

Oral versus transdermal selegiline: antidepressant-like activity in rats.

Gordon MN, Muller CD, Sherman KA, Morgan DG, Azzaro AJ, Wecker L.

Pharmacol Biochem Behav. 1999 Jul;63(3):501-6.

PMID:
10418793
14.

Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.

Ward HE, Johnson EA, Goodman IJ, Birkle DL, Cottrell DJ, Azzaro AJ.

Pharmacol Biochem Behav. 1998 May;60(1):209-15.

PMID:
9610944
15.

Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.

Barrett JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK, Darnow J, Azzaro AJ, DiSanto AR.

J Clin Pharmacol. 1997 Mar;37(3):238-47.

PMID:
9089426
18.

Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces.

Cratty MS, Ward HE, Johnson EA, Azzaro AJ, Birkle DL.

Brain Res. 1995 Mar 27;675(1-2):297-302.

PMID:
7796142
19.

In vivo microdialysis of corticotropin releasing factor (CRF): calcium dependence of depolarization-induced neurosecretion of CRF.

Gabr RW, Gladfelter WE, Birkle DL, Azzaro AJ.

Neurosci Lett. 1994 Mar 14;169(1-2):63-7.

PMID:
8047294
20.

Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.

Johnson EA, Tsai CE, Shahan YH, Azzaro AJ.

J Pharmacol Exp Ther. 1993 Jul;266(1):133-41.

PMID:
8101215
21.

Abnormal fatty acid composition in sarcolemma and sarcoplasmic reticulum from myotonic ADR mouse muscle.

Birkle DL, Shahamat V, Lucci J, Johnson EA, Riggs JE, Azzaro AJ.

Biochim Biophys Acta. 1993 Mar 14;1146(2):236-42.

PMID:
8383999
22.

Effects of withdrawal from chronic cocaine administration on behavior and beta-adrenergic and serotonergic brain receptors in rat.

Johnson EA, Goodman IJ, Shahan YH, Azzaro AJ.

Ann N Y Acad Sci. 1992 Jun 28;654:453-5. No abstract available.

PMID:
1352954
23.
24.

Dopamine D2 synthesis-modulating receptors are present in the striatum of the guinea pig.

Johnson EA, Tsai CE, Lucci J, Harrison-Shahan Y, Azzaro AJ.

Neuropharmacology. 1992 Jan;31(1):95-101.

PMID:
1347405
25.

The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.

Azzaro AJ, Amedro JB, Brown LM, Smith DJ, Williams GM.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Jul;338(1):9-13.

PMID:
2467212
28.

Inhibition of tyrosine hydroxylase in rabbit mesenteric artery and vas deferens by catechol oestrogens.

Panek DU, Azzaro AJ, Stitzel RE, Head RJ.

Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):243-9.

PMID:
2884573
29.

Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS.

Blier P, de Montigny C, Azzaro AJ.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):253-60.

PMID:
3808082
31.
34.

Role of type A and type B monoamine oxidase in the metabolism of released [3H]dopamine from rat striatal slices.

Schoepp DD, Azzaro AJ.

Biochem Pharmacol. 1982 Sep 15;31(18):2961-8. No abstract available.

PMID:
6814449
35.
36.
37.

Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.

Schoepp DD, Azzaro AJ.

J Neurochem. 1981 Jun;36(6):2025-31.

PMID:
6787175
38.

Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines.

Smith DJ, Azzaro AJ, Zaldivar SB, Palmer S, Lee HS.

Neuropharmacology. 1981 Apr;20(4):391-6. No abstract available.

PMID:
7290352
39.

The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.

Demarest KT, Smith DJ, Azzaro AJ.

J Pharmacol Exp Ther. 1980 Nov;215(2):461-8.

PMID:
7441510
40.

(+/-)-trans-2-(Aminomethyl)cyclobutanecarboxylic acid hydrochloride: a rigid analogue of gamma-aminobutyric acid.

O'Donnell JP, Johnson DA, Azzaro AJ.

J Med Chem. 1980 Oct;23(10):1142-4.

PMID:
7420361
41.

Alterations in the biochemical properties of central dopamine synapses following chronic postnatal PbCO3 exposure.

Wince LC, Donovan CA, Azzaro AJ.

J Pharmacol Exp Ther. 1980 Sep;214(3):642-50.

PMID:
7400966
42.

Preparation and biological actions of N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine.

O'Donnell JP, Azzaro AJ, Urquilla PR.

J Pharm Sci. 1980 Feb;69(2):149-52.

PMID:
7359313
43.

(3,4-Dihydroxybenzyl)-2-imidazoline (DHBI): an analogue of dopamine.

O'Donnell JP, Azzaro AJ, Urquilla PR.

Res Commun Chem Pathol Pharmacol. 1979 Nov;26(2):243-51.

PMID:
230552
45.

The disposition of tritiated dopamine by gills of Mytilus edulis and Modiolus demissus.

Young S, Malanga CJ, Azzaro AJ.

Comp Biochem Physiol C. 1977;58(1C):49-55. No abstract available.

PMID:
23241
46.

The effect of ketamine HC1 on the in vitro metabolism of norepinephrine in rat cerebral cortex tissue.

Smith DJ, Azzaro AJ, Turndorf H, Abbott SB.

Neuropharmacology. 1975 Jul;14(7):473-81. No abstract available.

PMID:
1153091
47.

Catecholamines and affective brain disorders.

Azzaro AJ, Gutrecht JA.

W V Med J. 1975 Jul;71(7):157-61. No abstract available.

PMID:
1057297
48.

The role of storage and catabolism in the accumulation of [3H]norepinephrine after short and long incubation times.

Azzaro AJ, Smith DJ.

J Neurochem. 1975 Apr;24(4):811-3. No abstract available.

PMID:
1123638
49.

The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.

Azzaro AJ, Ziance RJ, Rutledge CO.

J Pharmacol Exp Ther. 1974 Apr;189(1):110-8. No abstract available.

PMID:
4823286
50.

Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.

Azzaro AJ, Rutledge CO.

Biochem Pharmacol. 1973 Nov 15;22(22):2801-13. No abstract available.

PMID:
4761552

Supplemental Content

Loading ...
Support Center